Vice President of Business Development
Michael Johnson, Vice President of Business Development at Eli Lilly, explored the inside story of mergers and acquisitions with participants. Xavier Health Director Marla Phillips asked Michael: Do mergers and acquisitions ever really benefit the organization in the end, or do they just create churn and change that doesn’t improve the bottom line in the end? As a result, they decided to have this Lunch & Learn session to explore the following questions:
What are some reasons why corporations explore mergers and acquisitions?
What is your opinion on the effectiveness of mergers and acquisitions? Do they ever really work out as touted/hoped?
What are some typical business development options available, and when might each one be the right decision?
Hear about a side of mergers and acquisitions that isn’t often talked about, but is often experienced.